Abstract:

Abstract:

Abstract:

Abstract:
To maintain its profit margin, Arlene also believes in multitasking skills, she therefore created a lean and mean internal infrastructure all by standardization, key staff selection, dedication and appreciation of talents. Arlene's overall strategy and success was brought on with the mentality, that an accumulation of small success to becoming an aggregated success is more solid than going after big VC monies, and that mentality has continued GolfAchiever's profits and success to today.

Abstract:

This seminar is the continuation of Dr. C.T. Wu's 01/06/10 TAITA Seminar which addressed the following subject:

"With Buffet's unique experience of both business management and stock investment, he uncovered the biggest insight for stock investment, i.e. only invest in companies that have ‘Wide Moat", or simply put, companies that have sustainable competitive advantages that are very hard to copy by the competition.

A Systems Thinking Based Framework for Business Model Analysis was presented to facilitate the identification of Technology and Business Model Innovation type of companies that are truly "Wide Moat" in nature. This framework, in conjunction with a Regression Analysis Based Secular Bull/Bear Market Screening Framework, can significantly improve the odds of achieving superior investment returns over a time span of 5-10 years."

In the upcoming 10/11/10 TAITA Seminar, a unified system framework, as a direct result of the author’s 3-year intensive research work to synthesize many famous guru investors’ seemingly diverse investment strategies, will be presented with the intent to help the individual amateur investor to improve his/her investment caliber, or simply the Alpha, as is called in the Mutual Fund industry.

• Buffett: "If I were to run a business school, there will be only two courses offered: 1. How to Value a Business? 2. How Stock Market Behaves?
• Robert Haugen's New Finance and what went wrong with the Efficient Market Hypothesis and Modern Portfolio Theory
• Robert Siegel's Noisy Market Hypothesis and Fundamental Based Indexing
• Index Funds tend to add new momentum to short-term market momentums
• Most investors don't know how to determine the Fair Value of a Business - Why? What? And How?
• Ben Graham's Mr. Market Syndrome
• Haugen's 35-yr Stock Return Patterns Regression Analysis based on 12 factors
• Build a Unified Investment Benchmark Model - Don Yachtman's "Evaluate Stocks as Bonds"; Jeremy Grantham's "You can have free lunches by investing in High Quality stocks"; Mark Sells' "Take care of the downside risk and the upside potential will take care of itself"; Martin Whitman's "Buy growth, but don't pay for it!" --Why these four Guru Investors are the real "soul mates" of Warren Buffett?
• Peter Lynch--Finding Hidden Gems among Small/Micro-Cap stocks - Smell like a VC, enjoy high returns when a few good hits happen - The excitement not enjoyed by traditional value investors
• Key Criteria to spot tomorrow's High Quality Businesses today
• A 50/50 Balanced Portfolio - 50% Large-Cap Dividend Growth stocks; 50% Niche King Small/Micro-CAP stocks - Be a "Buffett/Lynch Hybrid"!
• What is a Guru Investor? - Being able to compound the investment at a 20+% Annualized Return Rate over the long term (per Mark Sellers)
• Profile of a Guru Investor - Kind Heart/Right Mind/Good Temper - No kidding here!
  

Abstract:

In the last 10 years most investors have seen their accounts take beatings and are hoping for positive results to get their portfolios back on track. However, many experts believe evidence is mounting that the current downward trend in the equity markets could extend for years or even a decade or more to come, and they shouldn't count on the markets bouncing back any time soon.

An emergent theory argues that the U.S. is in a "secular bear market," a long period in which equity markets experience flat or declining growth, punctuated by a series of bear market cycles. Additionally, there have been three other secular bears throughout history: the period from 1906 to 1921, the Great Depression period of 1929 to 1942, and from 1966 to 1982.

Churchill Management Group was founded in 1963 and has had the rare advantage of successfully navigating secular bear markets using an “active” process that seeks to participate in the cyclical “ups” in the market while attempting to avoid the cyclical “downs”. In this talk you will hear how the process originated and will learn about many of the indicators that help Churchill make their market decisions.

Abstract:

The impact of the Obama administration's incentive money coupled with the overwhelming desire to save energy and reduce carbon-dioxide emission have resulted in the Smart Grid drawing a lot of attention from the high tech industry. Through smart meter deployments in the state of California and across the nation, Smart Grid has transcended from becoming a high tech buzz word to affecting our everyday life.

In this talk we will introduce the concept of Smart Grid, its importance and how it affects us. We will explore how at the heart of the Smart Grid the communication systems will be used to improve the efficiency of power grid, reduce the consumer's energy consumption and will place knowledge and choice in the consumer’s hand. The underlying importance and impact to and of the IT industry, its role in Smart Grid deployment, and how we will make use of it will also be shown.

---

Highlight The House of Representatives passed the health care reform bill with a 219-to-212 vote in the evening on Sunday March 21, 2010. With the Senate already having passed the bill on Christmas Eve, President Obama wasted no time and signed into law on March 23, 2010. The health reform bills are now law in the US and will trigger sweeping changes and disruptions – some rather quickly and some over many years. There is little question that it will have far-reaching and lasting impacts to many industries and will affect millions of individuals in the United States. Everyone is asking, “What now?”

This landmark health care reform will have varying degrees of impacts to different industries and sectors of the economy. Facing potential new laws, there will be new challenges, but also opportunities, for the medical device industry, and for its entrepreneurs, investors, and operating companies in the field. The Speaker will discuss the implications of these new laws from the prospective of starting-up a new medical device business in the US, Taiwan, and China.

This seminar is intended to be an interesting and inter-active discussion session that you don’t want to miss.

---

When shall a man start to do his estate planning? It is never too early to plan. The best timing is when you have nothing. Sometime, you might need to spend extra efforts to get optimal when you have accumulated a lot of assets. The planning not only covers what you have earned but also what you will earn in the future.

It is not uncommon for Affluent Americans to have significant mistakes in their wealth transfer plans. Most do not understand the nature of the mistakes nor the fact that solutions exist. This seminar will cover the ten mistakes that are made most often in estate planning, which include Incapacity, Ownership, Tax Free Transfers, Qualified Plans, Charities, etc. It intends to help uncover your wealth transfer mistakes, provide you with information on some typical solutions, and help layout a “road map” or action plan for implementing these solutions. You will learn how to minimize your estate taxes while maximizing the assets you pass to your heirs.

To help you looking at a comprehensive financial planning, this seminar will also disclose “Lifetime Wealth Strategies”. The LWS is an integrated approach calculating your total economic wealth, including your “human capital”. It provides a dynamic investment strategy that respond to every stage of your life. It leverages rigorous research by Ibbotson Associates and incorporates state-of

---

Biomedical business has big opportunity due to a great demand from "aging population" and the arriving of “health reform”. Can the opportunity to gain knowledge for promoting your health also probably bring you wealth? Business with antibody and peptide enjoyed with double-digit numbers growth in the last decade and can be better for next decade. Especially, we note the following trend: (1) Antibodies are good diagnostic tools and also becoming important new drugs for diseases. There are 22 therapeutic monoclonal antibodies on the market and several hundred monoclonal antibodies either in human clinical trials or under review by the US FDA. The size of therapeutic antibody market is projected to reach between $26 and $39 billion in 2010. (2) Advances in peptide synthesis, delivery, and formulation techniques, peptides applications has become more mature and broad. Since yr 2000 the number of therapeutic peptides in clinical trial has doubled compared to the 1990s. Disregard the $3.5 billion anti-aging cosmedceuticals industry, 48 therapeutic peptides are now on the market worldwide, with 4 having generated global sales of more than $500 million each in 2007. Approximately 400 therapeutic peptides are now moving through the clinical trial process. What are the true drivers of new development? What are the challenges? What is the short- and long term market outlook? Several major pharmaceutical companies recently have acquired companies like Abgenix, PDL, Medarex, Rinat, and Genentech. Why? Here are three highly accredited panelists will share their views for the coming niches.

---